Literature DB >> 12381675

Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria.

A C Soares1, V S Pinho, D G Souza, T Shimizu, S Ishii, J R Nicoli, M M Teixeira.   

Abstract

The lipid mediator PAF plays an important role in the phagocytosis of particles, including bacteria, and consequent production of pro-inflammatory cytokines, such as TNF-alpha and IL-8. Using a PAF receptor antagonist (UK-74,505) and PAF receptor knock-out mice, we have investigated the relevance of PAF for the inflammatory changes and lethality after pulmonary infection with the gram-negative bacteria Klebsiella pneumoniae in mice. At an inoculum of 3 x 10(6) bacteria, there was marked pulmonary (bronchoalveolar lavage and lung) neutrophilia that started early (2.5 h after infection) and peaked at 48 h. All animals were dead by day 4 of infection. The chemokine KC and the pro-inflammatory cytokine TNF-alpha increased rapidly and persisted for 48 h in the lungs. Pretreatment with UK-74,505 (30 mg kg(-1) per day, p.o.) had no significant effects on the number of infiltrating neutrophils in BAL fluid or lung tissue, as assessed by histology and measuring myeloperoxidase, or on the concentrations of KC. In contrast, concentrations of TNF-alpha and the number of bacteria inside neutrophils were significantly diminished. In order to support a role for the PAF during K. pneumoniae infection, experiments were also carried out in PAFR-deficient mice. In the latter animals, lethality occurred earlier than in wild-type controls. This was associated with greater number of bacteria in lung tissue and diminished percentage of neutrophils containing bacteria in their cytoplasm. Our results suggest that PAF, acting on its receptor, plays a protective role during infection with K. pneumoniae in mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381675      PMCID: PMC1573539          DOI: 10.1038/sj.bjp.0704918

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models.

Authors:  Y Fukuda; H Kawashima; K Saito; N Inomata; M Matsui; T Nakanishi
Journal:  Eur J Pharmacol       Date:  2000-02-25       Impact factor: 4.432

2.  Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release.

Authors:  T Owaki; A Meneshian; K Maemura; S Takao; D Wang; K C Fuh; G B Bulkley; A S Klein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-01       Impact factor: 4.733

3.  Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection.

Authors:  T A Moore; M W Newstead; R M Strieter; B Mehrad; B L Beaman; T J Standiford
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

4.  Effects of tachykinin NK1 or PAF receptor blockade on the lung injury induced by scorpion venom in rats.

Authors:  I M Matos; D G Souza; D G Seabra; L Freire-Maia; M M Teixeira
Journal:  Eur J Pharmacol       Date:  1999-07-09       Impact factor: 4.432

5.  Possible participation of intracellular platelet-activating factor in tumor necrosis factor-alpha production by rat peritoneal macrophages.

Authors:  M Yamada; A Tanimoto; G Ichinowatari; H Yaginuma; K Ohuchi
Journal:  Eur J Pharmacol       Date:  1999-06-25       Impact factor: 4.432

6.  Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice.

Authors:  J C Aliberti; F S Machado; R T Gazzinelli; M M Teixeira; J S Silva
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

7.  Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.

Authors:  T Nagase; S Ishii; K Kume; N Uozumi; T Izumi; Y Ouchi; T Shimizu
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

8.  Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice.

Authors:  W C Tsai; R M Strieter; J M Wilkowski; K A Bucknell; M D Burdick; S A Lira; T J Standiford
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

9.  Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis.

Authors:  A Matsukawa; C M Hogaboam; N W Lukacs; P M Lincoln; R M Strieter; S L Kunkel
Journal:  Exp Mol Pathol       Date:  2000-04       Impact factor: 3.362

10.  Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.

Authors:  S Ishii; T Kuwaki; T Nagase; K Maki; F Tashiro; S Sunaga; W H Cao; K Kume; Y Fukuchi; K Ikuta; J Miyazaki; M Kumada; T Shimizu
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

View more
  16 in total

1.  Microbial pattern recognition receptors mediate M-cell uptake of a gram-negative bacterium.

Authors:  Peter Tyrer; A Ruth Foxwell; Allan W Cripps; Michael A Apicella; Jennelle M Kyd
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression.

Authors:  Elizabeth S Fernandes; Giselle F Passos; Maria M Campos; Glória E P de Souza; Juliana F Fittipaldi; Jorge L Pesquero; Mauro M Teixeira; João B Calixto
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

3.  Platelet-activating factor receptor blockade ameliorates Aggregatibacter actinomycetemcomitans-induced periodontal disease in mice.

Authors:  Mila Fernandes Moreira Madeira; Celso Martins Queiroz-Junior; Graciela Mitre Costa; Silvia Maria Cordeiro Werneck; Daniel Cisalpino; Gustavo Pompermaier Garlet; Mauro Martins Teixeira; Tarcília Aparecida Silva; Daniele G Souza
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

4.  Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice.

Authors:  Talles Prosperi de Paula; Patrícia Campi Santos; Raquel Duque do Nascimento Arifa; Angélica T Vieira; Ludmila de Matos Baltazar; Thiago Vinícius Ávila; Caio Tavares Fagundes; Zélia Menezes Garcia; Renata Lacerda Lima; Mauro Martins Teixeira; Danielle G Souza
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 5.  Microbial modulation of host immunity with the small molecule phosphorylcholine.

Authors:  Sarah E Clark; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

6.  Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.

Authors:  Kent Doi; Koji Okamoto; Kousuke Negishi; Yoshifumi Suzuki; Akihide Nakao; Toshiro Fujita; Akiko Toda; Takehiko Yokomizo; Yoshihiro Kita; Yasuyuki Kihara; Satoshi Ishii; Takao Shimizu; Eisei Noiri
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw.

Authors:  Elizabeth S Fernandes; Giselle F Passos; Maria M Campos; José G V C Araújo; Jorge L Pesquero; Maria C Avelllar; Mauro M Teixeira; João B Calixto
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

8.  Pneumonia-induced sepsis in mice: temporal study of inflammatory and cardiovascular parameters.

Authors:  Regina Sordi; Octávio Menezes-de-Lima; Ana M Della-Justina; Edir Rezende; Jamil Assreuy
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

9.  The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza.

Authors:  Jonathan A McCullers; Amy R Iverson; Raelene McKeon; Peter J Murray
Journal:  Scand J Infect Dis       Date:  2007-06-21

10.  Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.

Authors:  Danielle G Souza; Vanessa Pinho; Adriana C Soares; Takao Shimizu; Satoshi Ishii; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.